Company intelligence / Profile preview

NewMarket

Ownership: Public · NEU
Development stage: Commercial

Overview

Newmarket Biomedical is a UK-based company specializing in the manufacture and global distribution of high-quality in-vitro diagnostic reagents, with a primary focus on serological syphilis antibody detection. Their products are ISO 13485 certified and CE marked under European regulations. The company has over a decade of operational history and emphasizes regulatory compliance, manufacturing capacity, and customer service excellence. They supply blood banks, clinical laboratories, and testing centers worldwide.

Therapeutic areas: Infectious Diseases
Modalities: In-vitro diagnostic reagents and test kits
Industry: Protein Biomarker Diagnostics

Partnerships

British Standards Institute for regulatory compliance work

Beyond the preview

Go deeper on NewMarket.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NewMarket.

Explore the full profile